Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

         

 Advertising by Adpathway

Thermax shares fall 20% to 52-week low on weak Q2, JM Financial maintains sell

4 hours ago 7

PROTECT YOURSELF with Orgo-Life® QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

  Advertising by Adpathway

Thermax shares hit a 52-week low on Friday, falling close to 20 per cent following the company’s second-quarter results for FY27, as net profit attributable to equity shareholders declined compared with the year-ago period.

The company reported a net profit of ₹114.54 crore in Q2FY27, down from ₹119.66 crore in Q2FY26. However, revenue from operations increased marginally to ₹2,755.87 crore during the quarter under review.

Thermax has raised its H2 FY27 revenue guidance to above ₹7,000 crore, compared with its earlier guidance of ₹3,000 crore per quarter.

The management expects double-digit revenue growth in both Q3 and Q4 of FY27, driven by strong execution of its backlog.

JM Financial maintained its sell rating on Thermax with a sum-of-the-parts (SotP)-based target price of ₹3,435.

The brokerage said its target price implies a price-to-earnings multiple of 45 times on H1FY29E estimates. It retained its sell recommendation.

JM Financial also noted that the stock had corrected sharply, declining 23 per cent following the Q1FY27 results.

Published on November 6, 2026

Read Entire Article

         

        

Start the new Vibrations with a Medbed Franchise today!  

Protect your whole family with Quantum Orgo-Life® devices

  Advertising by Adpathway